GENESYS.NSGENESYS.NSNSE
Loading
EBITDA Over TimeContracting
Percentile Rank93
3Y CAGR+26.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+26.0%/yr
vs +31.3%/yr prior
Acceleration
-5.3pp
Decelerating
Percentile
P93
Near historical high
vs 3Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.30B-11.1%
2025$1.46B+69.9%
2024$862.12M+32.3%
2023$651.43M+556.7%
2022$-142.65M+56.2%
2021$-325.67M-290.6%
2020$170.83M-22.1%
2019$219.15M-39.0%
2018$359.27M+86.3%
2017$192.83M-